TORRENT PHARMACEUTICALS LTD. - Board Meeting Intimation for Consider And Approve The Audited Financial Results On Standalone Basis And Unaudited Financial Results (With Limited Review) On Consolidated Basis Of The Company For The Quarter Ended On 30-Jun-24.

TORRENT PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/07/2024 ,inter alia, to consider and approve We would like to inform you that a meeting of the Board of Directors will be held on Tuesday, 23-Jul-24, inter alia, to consider and approve the Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company for the quarter ended on 30-Jun-24.